Search Within

Andrew Lassman

Formats
  1. Journal Article (63)
  2. Meeting Abstract (43)
  3. Book Section (5)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (51)
  2. Epidemiology and Biostatistics (29)
  3. Biostatistics Service (28)
  4. Population Sciences Research Program (26)
  5. GSK Faculty (20)
  6. Radiology, Department of (20)

More Groups

People
  1. Lauren Abrey (49)
  2. Lisa De Angelis (49)
  3. Katherine Panageas (25)
  4. Craig Nolan (19)
  5. Igor Gavrilovic (18)
  6. Adilia Hormigo (16)

More People

Years
  1. 2020 (1)
  2. 2019 (2)
  3. 2017 (1)
  4. 2015 (2)
  5. 2014 (3)
  6. 2013 (5)

More Years

Publications
  1. Neuro-Oncology (38)
  2. Journal of Clinical Oncology (21)
  3. Journal of Neuro-Oncology (14)
  4. Clinical Cancer Research (4)
  5. International Journal of Radiation Oncology, Biology, Physics (4)
  6. Neurology (3)

More Publications

Publishers
  1. Oxford University Press (38)
  2. American Society of Clinical Oncology (21)
  3. Springer (19)
  4. Elsevier Inc. (8)
  5. American Association for Cancer Research (5)
  6. Lippincott Williams & Wilkins (4)

More Publishers

Results (111)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma
    Journal Article

    Iwamoto, F. M.; Abrey, L. E.; Beal, K.; Gutin, P. H.; Rosenblum, M. K.; Reuter, V. E.; Deangelis, L. M.; Lassman, A. B.
    Neurology (2009)

    Fulltext@MSK | Save
  • Bevacizumab for recurrent ependymoma
    Journal Article

    Green, R. M.; Cloughesy, T. F.; Stupp, R.; Deangelis, L. M.; Woyshner, E. A.; Ney, D. E.; Lassman, A. B.
    Neurology (2009)

    Fulltext@MSK | Save
  • Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma
    Journal Article

    Clarke, J. L.; Iwamoto, F. M.; Sul, J.; Panageas, K.; Lassman, A. B.; DeAngelis, L.; Hormigo, A.; Nolan, C. P.; Gavrilovic, I.; Karimi, S.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Risk factors for malignant spinal cord compression and leptomeningeal metastases in cancer patients presenting to an urgent care center
    Meeting Abstract

    Klotz, A. D.; Lassman, A. B.; Shi, W.; Thayler, H.; Groeger, J.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Pseudoprogression (PsPr) after concurrent radiotherapy (RT) and temozolomide (TMZ) for newly diagnosed glioblastoma multiforme (GBM)
    Meeting Abstract

    Clarke, J. L.; Abrey, L. E.; Karimi, S.; Lassman, A. B.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Patterns of relapse and prognosis after bevacizumab (BEV) failure in recurrent glioblastoma (GBM)
    Meeting Abstract

    Lassman, A. B.; Iwamoto, F. M.; Gutin, P. H.; Abrey, L. E.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma
    Meeting Abstract

    Ney, D.; DeAngelis, L.; Nolan, C.; Gavrilovic, I.; Hormigo, A.; Lassman, A.; Abrey, L.
    Neuro-Oncology (2008)

    Fulltext@MSK | Save
  • Phase II trial of dasatinib for recurrent glioblastoma (rtog 0627)
    Meeting Abstract

    Lassman, A.; Wang, M.; Gilbert, M.; Aldape, K.; Wright, J.; Wagner, H.; Brachman, D.; Malkin, M.; Mehta, M.
    Neuro-Oncology (2008)

    Fulltext@MSK | Save
  • Tumor sequestration of lapatinib (NABTC 04-01)
    Meeting Abstract

    Kuhn, J.; Robins, I.; Mehta, M.; Fine, H.; Cloughesy, T.; Wen, P.; Chang, S.; DeAngelis, L.; Lieberman, F.; Reardon, D.; more...
    Neuro-Oncology (2008)

    Fulltext@MSK | Save
  • Pseudoprogression (Pspr) after concurrent radiotherapy (Rt) and temozolomide (Tmz) for newly diagnosed glioblastoma multiforme (GBM)
    Meeting Abstract

    Clarke, J.; Abrey, L.; Karimi, S.; Lassman, A.
    Neuro-Oncology (2008)

    Fulltext@MSK | Save